Ovarian Cancer Research Alliance Joins with Rivkin Center for Ovarian Cancer Research, Strengthening the Fight Against Ovarian Cancer OCRA to Expand its Research Initiatives by Integrating Rivkin Center’s Legacy Efforts, Effective April 2025 NEW YORK, NY, January 28, 2025 – Ovarian Cancer Research Alliance (OCRA), the world’s leading gynecologic cancer nonprofit, is proud to announce […]
Read MoreGeneral For the PNW Ovarian Cancer Community For the Ovarian Cancer Research Community Related Pages A message from our CEO, Molly O’Connor A message from the Rivkin Family A video message from Dr. Rivkin & Melissa Rivkin Press release Rivkin Center joins OCRA
Read More
Dear Rivkin Center Community, Today, we announce that, after more than 30 years of advancing ovarian cancer research and education, the Rivkin Center for Ovarian Cancer Research will combine with Ovarian Cancer Research Alliance (OCRA). This change will take place on April 1, 2025. This new partnership is a testament to the Rivkin Center’s three […]
Read More
Dear Rivkin Center Family, From the beginning, the Rivkin Center for Ovarian Cancer Research has been deeply personal for our family. Thirty years ago, we came together to honor our wife and mother, Marsha Rivkin, creating a legacy that reflects the love, compassion, and warmth she shared with us. Today, we share an important new […]
Read MoreThis week the Rivkin Center was featured in the Mercer Island Reporter, recognized for its groundbreaking efforts to advance ovarian cancer research through community-driven support. The article highlights how a pivotal $270,000 gift, along with contributions from other generous donors, unlocked $1 million in funding for ovarian cancer research in Washington state. From funding innovative […]
Read More
“Scientists came to share, collaborate, and change the future of ovarian cancer research.” World-class researchers and rising stars in ovarian cancer research came together this past weekend for the Rivkin Center’s 15th Biennial Ovarian Cancer Research Symposium in the Seattle area. The goal: advance knowledge and shape the future of treatment and prevention – and get […]
Read More
September marks ovarian cancer awareness month, a time to spotlight a disease that affects thousands of women each year. This month is an opportunity to educate the public about ovarian cancer, support those affected, and push for critical research funding. Although informally recognized for decades, the Biden administration officially declared September as Ovarian Cancer Awareness […]
Read MoreThe Rivkin Center has awarded Dr. Zachary Watson, PhD, assistant professor atUniversity of Colorado School of Medicine, a $75,000 grant to investigate the development of ovariancancer in post-menopausal women. Rivkin Center Pilot Study Awards fund novel, innovative ideas thatare in the early stages of discovery. About his research: Dr. Watson will investigate a potential driver […]
Read MoreResearch to help fast-track new treatment for low-grade serous ovarian cancer Seattle, WA – The Rivkin Center has awarded Dr. Utthara Nayar, PhD, associate professor at theJohns Hopkins University’s Bloomberg School of Health, a $75,000 grant to help her fast-track clinicaltesting of a new treatment for ovarian cancer. Rivkin Center Pilot Study Awards fund novel, […]
Read MoreScientific awards also given to researchers at Johns Hopkins University and University of Colorado Seattle, WA – In a bold move for ovarian cancer research in Washington state, the Rivkin Center forOvarian Cancer Research, in partnership with the state’s Andy Hill Cancer Research Endowment (CARE)Fund, announced today the 2024 recipients of the new Rivkin Center/CARE […]
Read MoreFunds to support innovation and answers in WA state research institutions Sept. 21, 2023 For Immediate Release Molly O’Connor, CEO(206) 490-0878; molly.oconnor@rivkin.org SEATTLE – Washington state ovarian cancer researchers will have an extra $1M in grant funding over the next two years thanks to a pioneering public-private partnership between the Rivkin Center for Ovarian Cancer […]
Read MoreThe Rivkin Center is pleased to add three new board members to its board of directors. These board members bring a wealth of experience, both healthcare-related as well as fundraising, to the board and have hit the ground running in support of the Rivkin Center’s mission. Amy P. Sing, M.D. Dr. Amy P. Sing has […]
Read MoreStarting April 1, 2025, the Rivkin Center’s ovarian cancer research funding, global symposium and fundraising activities will continue under the leadership of Ovarian Cancer Research Alliance (OCRA).
